CBLI

Cleveland BioLabs, Inc. News Headlines

$0.2711
*  
0.0069
2.48%
Get CBLI Alerts
*Delayed - data as of Dec. 26, 2014 12:44 ET  -  Find a broker to begin trading CBLI now
Exchange: NASDAQ
Industry: Health Care
Community Rating:
View:    CBLI Real Time
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save Stocks
Viewing
Filtered By
Ordered By
Sector Update: Health Care Stock Turn Lower; Cleveland BioLabs Lights Up After FDA Approves Radiation Treatment
9/3/2014 2:59:31 PM - MT Newswires


Sector Update: Health Care
9/3/2014 2:58:53 PM - MT Newswires


Good News for Cleveland BioLabs - Analyst Blog
4/17/2014 4:20:01 PM - Zacks.com


Healthcare Stocks Ending with Losses; Cleveland Labs Falls to Record Low After Partner Pulls Plug on Radiation Treatment
1/23/2014 3:51:46 PM - MT Newswires


Sector Update: Healthcare
1/23/2014 3:50:38 PM - MT Newswires


Sector Update: Healthcare Stocks Lower; CBLI Slides 42% on Abandoned Development Plans
1/23/2014 8:46:01 AM - MT Newswires


Sector Update: Healthcare
1/23/2014 8:44:30 AM - MT Newswires


Sector Update: Healthcare Shares Flat to Higher; Cleveland BioLabs Cuts Net Loss in Half Year-Over-Year
8/13/2013 7:11:41 AM - MT Newswires


Sector Update: Healthcare
8/13/2013 7:10:55 AM - MT Newswires


Pre-Market Earnings Report for August 13, 2013 : VAL, FLO, AG, GENT, SCR, CACH, CBLI, PFSW, CIMT, ENSV
8/12/2013 3:00:04 PM - NASDAQ.com News


Profiting From BARDA Contract Awards
5/22/2013 1:33:00 PM - Seeking Alpha


Isis Initiates ISIS-STAT3 Study - Analyst Blog
5/7/2013 5:23:52 PM - Zacks.com


Negative Opinion on AVEO/ALPMY Candidate - Analyst Blog
5/3/2013 4:30:50 PM - Zacks.com


Loss at Aegerion Narrower Than Expected - Analyst Blog
5/3/2013 3:29:09 PM - Zacks.com


Gilead Misses on Earnings, Sales in 1Q - Analyst Blog
5/3/2013 7:29:01 AM - Zacks.com


Affymetrix Reports Disappointing 1Q - Analyst Blog
5/2/2013 7:49:01 AM - Zacks.com


Vertex Loss Lower, Kalydeco Outlook Up - Analyst Blog
5/1/2013 7:49:18 AM - Zacks.com


Merck - Pfizer in Diabetes Deal - Analyst Blog
4/30/2013 2:51:20 PM - Zacks.com


Double Setback for Gilead - Analyst Blog
4/30/2013 2:47:55 PM - Zacks.com


CHMP in Favor of Celgene's Revlimid - Analyst Blog
4/29/2013 3:49:04 PM - Zacks.com


Geron Narrows Loss; Cuts Jobs - Analyst Blog
4/29/2013 9:03:23 AM - Zacks.com


Earnings Increase at The Medicines Co. - Analyst Blog
4/26/2013 4:22:26 PM - Zacks.com


Biogen's Earnings Surpass Expectations - Analyst Blog
4/25/2013 11:14:51 AM - Zacks.com


Isis Pharma's ISIS-SMNRx Progresses - Analyst Blog
4/24/2013 4:09:50 PM - Zacks.com


Tax Benefit Boosts Amgen Earnings - Analyst Blog
4/24/2013 11:56:01 AM - Zacks.com